Skip to main content

Table 1 Baseline characteristics of the enrolled patients

From: Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices

Characteristics

Values (N = 36)

Age (years)

71 (40–84)

Sex (male/female)

24/12

Etiology of cirrhosis

 

 Alcohol

9 [25.0%]

 Hepatitis B virus

5 [13.9%]

 Hepatitis C virus

13 [36.1%]

 Others

9 [25.0%]

Laboratory data

 

 Albumin (g/dL)

3.5 (1.7–4.7)

 Total bilirubin (mg/dL)

1.0 (0.4–4.0)

 Prothrombin time (%)

81 (45–107)

 Platelet count (× 103/µL)

102 (56–402)

 Aspartate aminotransferase (IU/L)

25 (18–133)

 Alanine aminotransferase; (IU/L)

25 (4–81)

 γ-Glutamyl transpeptidase (IU/L)

64 (12–351)

 Ammonia (µg/dL)

55 (14–101)

Child–Pugh class (A/B/C)

22/12/2

Presence of splenomegaly

30 [83.3%]

Fib-4 index

4.79 (0.67–16.38)

Gastric variceal bleeding

7 [19.4%]

Co-existence of esophageal varices

23 [63.9%]

History of hepatocellular carcinoma

18 [50.0%]

Diameter of LGV before BRTO

4.5 (1–12)

Liver stiffness measurement (kPa)

30.2 (5.2–75.0)

Pre-HVPG (mmHg)

13 (1–25)

Post-HVPG (mmHg)

13 (5–25)

  1. Continuous data are presented as the median and range, and categorical data are presented as the number of patients
  2. LGV, left gastric vein; BRTO, balloon-occluded retrograde transvenous obliteration; HVPG, hepatic venous pressure gradient; Pre-HVPG, HVPG measured before BRTO; Post-HVPG, HVPG measured after BRTO